---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-032732"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2025-04-17T23:59:59+00:00"
generated_at: "2026-05-23T12:26:59.432716+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics files ATM prospectus supplement for up to 2.17M shares; $7.7M already sold

## Summary
- Filed prospectus supplement to sell up to 2,169,272 shares of common stock via ATM program with H.C. Wainwright.
- Company had sold $7,655,240 in common stock under the existing ATM agreement as of the filing date.
- Wainwright earns 3.0% commission on gross proceeds from any sales under the ATM agreement.
- Company may suspend or terminate the offering at any time; no obligation to sell shares.

## SEC filing metadata
- accession: 0001213900-25-032732
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2025-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/0001213900-25-032732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/ea0238567-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-032732
- JSON: https://secwatch.observer/filing/0001213900-25-032732.json
- Plain text: https://secwatch.observer/filing/0001213900-25-032732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.